Resumen de acción ELOS B
Elos Medtech AB (publ) engages in the development and contract manufacturing of medical devices and components for dental, orthopedics, diagnostics, and hearing and other medical device markets.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Competidores de Elos Medtech AB (publ)
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | kr203.00 |
| 52 Week High | kr295.00 |
| 52 Week Low | kr185.00 |
| Beta | 1.12 |
| 1 Month Change | -5.14% |
| 3 Month Change | -8.14% |
| 1 Year Change | -17.31% |
| 3 Year Change | 96.14% |
| 5 Year Change | 195.92% |
| Change since IPO | 1,253.33% |
Noticias y actualizaciones recientes
Recent updates
Calculating The Fair Value Of Elos Medtech AB (publ) (STO:ELOS B)
Oct 11
Is Now The Time To Look At Buying Elos Medtech AB (publ) (STO:ELOS B)?
May 23Here's Why I Think Elos Medtech (STO:ELOS B) Is An Interesting Stock
May 10Returns On Capital Are Showing Encouraging Signs At Elos Medtech (STO:ELOS B)
Apr 17We Think Elos Medtech (STO:ELOS B) Is Taking Some Risk With Its Debt
Mar 24Should Elos Medtech AB (publ) (STO:ELOS B) Be Part Of Your Dividend Portfolio?
Mar 11The President & CEO of Elos Medtech AB (publ) (STO:ELOS B), Jan Wahlström, Just Bought 28% More Shares
Feb 28Do Fundamentals Have Any Role To Play In Driving Elos Medtech AB (publ)'s (STO:ELOS B) Stock Up Recently?
Feb 24Elos Medtech (STO:ELOS B) Has Gifted Shareholders With A Fantastic 102% Total Return On Their Investment
Feb 11When Should You Buy Elos Medtech AB (publ) (STO:ELOS B)?
Jan 31How Much Are Elos Medtech AB (publ) (STO:ELOS B) Insiders Taking Off The Table?
Jan 18
Returns On Capital At Elos Medtech (STO:ELOS B) Paint An Interesting Picture
Jan 06Could The Elos Medtech AB (publ) (STO:ELOS B) Ownership Structure Tell Us Something Useful?
Dec 26Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet
Dec 13Here's Why We Don't Think Elos Medtech's (STO:ELOS B) Statutory Earnings Reflect Its Underlying Earnings Potential
Nov 30Elos Medtech AB (publ)'s (STO:ELOS B) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Nov 17Rentabilidad de los accionistas
| ELOS B | SE Medical Equipment | Mercado SE | |
|---|---|---|---|
| 7D | 0.5% | 0.4% | 1.7% |
| 1Y | -17.3% | -3.5% | 14.1% |
Rentabilidad vs. Industria: ELOS B obtuvo unos resultados inferiores a los del sector Swedish Medical Equipment , que el año pasado arrojó un rendimiento del -13.6%.
Rentabilidad vs. Mercado: ELOS B obtuvo unos resultados inferiores a los del mercado Swedish, que fue del 7.8% el año pasado.
Volatilidad de los precios
| ELOS B volatility | |
|---|---|
| ELOS B Average Weekly Movement | 3.7% |
| Medical Equipment Industry Average Movement | 7.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in SE Market | 13.3% |
| 10% least volatile stocks in SE Market | 3.6% |
Precio estable de las acciones: ELOS B no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de ELOS B (4%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1923 | 653 | Stefano Alfonsi | elosmedtech.com |
Resumen de fundamentos de Elos Medtech AB (publ)
| Estadísticas fundamentales de ELOS B | |
|---|---|
| Capitalización bursátil | kr5.73b |
| Beneficios(TTM) | kr54.95m |
| Ingresos (TTM) | kr1.02b |
104.3x
Ratio precio-beneficio (PE)5.6x
Ratio precio-ventas (PS)¿Está ELOS B sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de ELOS B | |
|---|---|
| Ingresos | kr1.02b |
| Coste de los ingresos | kr676.62m |
| Beneficio bruto | kr341.02m |
| Otros gastos | kr286.07m |
| Beneficios | kr54.95m |
Últimos beneficios comunicados
Sep 30, 2023
Próxima fecha de beneficios
Feb 29, 2024
| Beneficios por acción (BPA) | 1.95 |
| Margen bruto | 33.51% |
| Margen de beneficio neto | 5.40% |
| Ratio deuda/patrimonio | 51.6% |
¿Cómo se ha desempeñado ELOS B a largo plazo?
Ver rendimiento histórico y comparativa